Homocysteine levels and platelet aggregation in patients with cerebral circulatory disorders
- Authors: Sabaliauskiene Z1, Gribauskas P2, Gaigalaite V3, Ptašekas J4, Ojeraitene V3, Kalibatene D3
-
Affiliations:
- Pecпyбликaнcкая вильнюсская университетская больница
- Институт кардиологии Каунасского медицинского университета
- Вильнюсский университет
- ЗАО "Диагноститнес системос" (Диагностические системы)
- Issue: Vol 85, No 3 (2013)
- Pages: 75-79
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31239
- ID: 31239
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Z Sabaliauskiene
Pecпyбликaнcкая вильнюсская университетская больница
Email: Z.Sabaliauskiene@gmail.com
P Gribauskas
Институт кардиологии Каунасского медицинского университета
Email: prangryb@med.kmu.lt
V Gaigalaite
Вильнюсский университет
Email: gaigalaitevirginija@gmail.com
J Ptašekas
ЗАО "Диагноститнес системос" (Диагностические системы)
Email: diagnostinessistemos@mail.lt
V Ojeraitene
Вильнюсский университет
Email: violeta.ozeraitiene@mf.vu.lt
D Kalibatene
Вильнюсский университет
Email: danute.kalibatiene@mf.vu.lt
References
- Born G.V.R. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194: 927-929.
- Shipchandler M.T., Moore E.G. Rapid, fully automated measurement of plasma homocyst(e)ine with the Abbott IMX analyser. Clin Chem 1995; 41: 991-994.
- Ueland P.M., Refsum H., Beresford S.A. et al. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000; 72 (2): 333- 334.
- Milosevič-Tosič M., Borota J. Hyperhomocysteinemia - a risk factor for development of occlusive vascular diseases. Med Pregl 2002; 55 (9-10): 385-391.
- Dionisio N., Jardin I., Salido G.M., Rosado J.A. Homocysteine, intracellular signaling and thrombotic disorders. Curr Med Chem 2010; 17 (27): 3109-3119.
- Garalienė V. The main determinants of endothelial dysfunction. Medicina (Kaunas) 2006; 42 (5): 362-369.
- Alam M.M., Mohammad A.A., Shualb U. et al. Homocysteine reduces endothelial progenitor cells in stroke patients throught apoptosis. J Cereb Blood Flow Metab 2009; 29 (1): 157-165.
- Mohan I.V., Jagroop I.A., Mikhailidis D.P. et al. Homocysteine activates platelets in vitro. Clin Appl Thromb Hemost 2008; 14: 8-18.
- Karolczak K., Olas B. Mechanizm of action of homocysteine and its thiolactone in hemostasis system. Physiol Res 2009; 58 (5): 623-633.
- Luo F., Liu X., Wang S., Chen H. Effect of homocysteine on platelet activation induced by collagen. Nutrition 2006; 22 (1): 69-75.
- Riba R., Nicolaou A., Troxler M. et al. Altered platelet reactivity in peripheral vascular disease complicated with elevated plasma homocysteine levels. Atherosclerosis 2004; 175 (1): 69-75.
- Bigalke B., Schuster A., Sopova K. et al. Platelets in atherothrombosis - diagnostic and prognostic value of platelet activation in patients with atherosclerotic diseases. Curr Vasc Pharmacol 2012; 10 (5): 589-596.
- Santarelli L., Gabrielli M., Cremonini F. et al. Atrophic gastritis as a cause of hyperhomocysteinaemia. Aliment Pharmacol Ther 2004; 19 (1): 107-111.
- Zoccali C., Jager K.J. Hyperhomocysteinemia: a renal and cardiovascular risk factor? Nat Rev Nephrol 2010; 6 (12): 695-696.
- Goldstein L.B., Adams R., Alberts M.J. et al. Primary Prevention of ischemic stroke: a guideline from the American Heart Assotiation/American Stroke Assotiation Stroke Counsil: cosponsored by the Atherosclerotic Peripheral Vascular Disease Interdisciplinary Working Group. Stroke 2006; 37 (6): 1583-1633.
- Manolescu B.N., Oprea E., Farcasanu I.C. et al. Homocysteine and vitamin therapy in stroke prevention and treatment: a review. Acta Biochim Pol 2010; 57 (4): 467-477.
- Origlia C., Pescarmona G., Capizzi A. et al. Platelet cGMP inversely correlates with age in healthy subjects. J Endocrinol Invest. 2004; 27 (2): 1-4.
- Aronow W.S. Association Between Plasma Homocysteine and Vascular Atherosclerotic Disease in Older Persons. Prevent Cardiol 2000; 3 (2): 89-91.
![](/img/style/loading.gif)